Report copyright - Dept Hematology Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia (MMM): a phase II trial. Marchetti
Please pass captcha verification before submit form
Please pass captcha verification before submit form